Ayala Pharmaceuticals, Inc.
USD0.60
+0.00 (+0.00%)
CEO
Kenneth A. Berlin
IPO Date
2020-05-08
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.10
Prev. Close
$0.60
Day Low
$0.08
Day High
$0.60
52W Low
$0.00
52W High
$0.80
Market Cap
$0.03B
Volume
0.01M
| 1,500,000 |
| $0.40 |
| 6 Mar 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Disposed | 3,750,000 | $0.40 |
| 6 Mar 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Acquired | 2,250,000 | $0.40 |
| 6 Mar 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Acquired | 1,500,000 | $0.40 |
| 6 Mar 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Disposed | 3,750,000 | $0.40 |
| 12 Feb 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Acquired | 8,062,500 | $0.40 |
| 12 Feb 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | F-InKind | Disposed | 2,586,905 | $1.25 |
| 12 Feb 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | M-Exempt | Acquired | 8,437,500 | $0.40 |
| 12 Feb 2024 | Israel Biotech Fund I, L.P. | director, 10 percent owner: | F-InKind | Disposed | 2,707,581 | $1.25 |